Abstract
Aim. To assess sensitivity of SMG/MBI for diagnosis of minimal breast cancer (BC) and multicentric (MC) tumors in patients with different BC subtypes
Material and methods. We analyzed results of SMG/MBI that was performed in 1 080 women (2 154 mammary glands) with suspected BC. Breast imaging was performed 15-20 min after i/v injection of 370-740 MBq of 99mTc-MIBI. Verification of changes was carried out by morphological examination in 1 060 cases, and by dynamic observation in the remaining cases. Minimal forms classified as the lesions up to 10 mm in diameter. Minimal BC was detected in 178 patients. MCBC was diagnosed when SMG/MBI revealed two or more foci in different quadrants or within the same quadrant at least 30 mm apart.
Results. Sensitivity of SMG/MBI in diagnosis of minimal BC was 82%. In patients with different biological subtypes of BC, the sensitivity of SMG/MBI was as follows: 76% for luminal А, 80% - luminal В, 91% - luminal В+, 90% - triple negative and 100% for HER2 positive. The sensitivity of SMG/MBI in diagnosis of minimal Triple-negative and HER2-positive BC was significantly higher (p = 0.02).
The frequency of visualizing MCBC varied depending on the biological subtypes -19 cases (20.2%) for HER2-positive, which was significantly higher (p = 0.006) compared to other molecular-biological subtypes: Luminal A — 25 cases (10.5%), Luminal B — 41 cases (11.4%), Luminal B+ — 19 cases (12.6%), Triple-negative — 18 cases (10.3%).
Conclusion. SMG/MBI demonstrate the highest sensitivity in diagnosis of minimal BC of most aggressive subtypes (90% in triple-negative and 100% - in HER2-positive BC). 122 patients (12%) had multicentric BC with the highest frequency (20.2 %) in women with HER2-positive BC.
References
Krzhivitskiy P, Novikov S, Kanaev S, Krivorotko P, eds. Radionanotargeting and precision radiotherapy planning in patients with breast cancer. the evolution of radionanotargeting towards clinical precision oncology: a festschrift in honor of Kalevi Kairemo. 2022;79-90. doi:10.2174/9781681088655122010009.
Канаев С.В., Новиков С.Н., Семиглазов В.Ф., и др. Перспективы использования методов ядерной медицины у больных раком молочной железы. Вопросы онкологии. 2009;(6):661-670 [Kanaev SV, Novikov SN, Semiglazov VF, et al. Prospects for the use of nuclear medicine methods in patients with breast cancer. Voprosy Onkologii. 2009;(6):661-670 (In Russ.)].
Криворотько П.В. Диагностическая значимость маммографии и маммосцинтиграфии при мультицентричном раке молочной железы. Вопросы онкологии.2013;59(1):59-64 [Krivorotko P.V. Diagnostic value of mammography and mammoscintigraphy in multicentric breast cancer. Voprosy Onkologii. 2013;59(1):59-64 (In Russ.)].
Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011;22:1736-1747. doi:10.1093/annonc/mdr304.
Hui Tan, Hongwei Zhang, Weige Yang, et al. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics. Nucl Med Commun. 2016;37(8):792-799. doi:10.1097/MNM.0000000000000518.
Li H, Liu Z, Yuan L, et al. Radionuclide-based imaging of breast cancer: state of the art. cancers. 2021;13(21):5459. doi:10.3390/cancers13215459.
Чёрная А.В., Канаев С.В., Новиков С.Н., Крживицкий П.И., и др. Диагностическая значимость маммографии и маммосцинтиграфии с 99м Тс-MIBI при выявлении минимального рака молочной железы. Вопросы онкологии.2017;63(2):274-280 [Chernaya AV, Kanaev SV, Novikov SN, Krzhivitskiy PI, et al. Diagnostic accuracy of mammography and mammoscintigraphy with 99m Тс-MIBI in detection of minimal breast cancer. Problems in oncology. 2017;63(2):274-80 (In Russ.)]. doi:10.37469/0507-3758-2017-63-2-274-280.
Попова Н.С., Новиков С.Н., Крживицкий П.И., и др. Диагностические возможности маммосцинтиграфии и метода молекулярной визуализации молочных желез при выявлении различных биологических подтипов рака молочной железы. Опухоли женской репродуктивной системы. 2022;18(3):14-23 [Popova NS, Novikov SN, Krzhivitskiy PI, et al. Diagnostic capabilities of breast scintigraphy and molecular imaging of the mammary glands in the detection of various biological subtypes of breast cancer. Tumors of female reproductive system. 2022;18(3):14-23 (In Russ.)]. doi:10.17650/1994-4098-2022-18-3-14-23.
Тицкая А.А., Чернов В.И., Слонимская Е.М., и др. Маммосцинтиграфия с 99mTс-МИБИ в диагностике рака молочной железы//Сибирский медицинский журнал. 2010;25(4):92–95 [Titskaya AA, Chernov VI, Slonimskaya EM, et al. Mammoscintigraphy with 99mTc-MIBI in the diagnosis of breast cancer. Siberian Scientific Medical Journal. 2010;25(4):92-95 (In Russ).].
Conners AL, Hruska CB, Tortorelli CL, et al. Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy. European Journal of Nuclear Medicine and Molecular Imaging. 2012;39(6):971-82. doi:10.1007/s00259-011-2054-z.
Novikov SN, Chernaya AV, Krzhivitsky PI, et al. 99mTc-MIBI scintimammography and digital mammography in the diagnosis of multicentric breast cancer. Hell J Nucl Med. 2019;22(3):172-178. doi:10.1967/s002449911052.
Edwards C, Williams S, McSwain AP, et al. Breast-specific gamma imaging influences surgical management in patients with breast cancer. Breast J. 2013;19(5):512-9. doi:10.1111/tbj.12147.
Zhang Y, Ren H. Meta-analysis of diagnostic accuracy of magnetic resonance imaging and mammography for breast cancer. J Cancer Res Ther. 2017;13(5):862-868. doi:10.4103/jcrt.JCRT_678_17.
Liberman M, Sampalis F, Mulder DS, et al. Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature. Breast Cancer Research and Treatment. 2003;80:115-126.
Канаев С.В., Новиков С.Н, Криворотько П.В., и др. Методические аспекты радионуклидной диагностики рака молочной железы с помощью 99 МТС-технетрила. Вопросы онкологии.2012;58(6):768-772 [Kanaev SV, Novikov SN, Krivorotko PV, et al. Methodological aspects of radionuclide diagnosis of breast cancer using 99 MTS-technetril. Voprosy Onkologii. 2012;58(6):768-772 (In Russ.)].
Groheux D, Hindie E. Breast cancer: initial workup and staging with FDG PET/CT. Clin Transl Imaging. 2021;9:221-231. doi:10.1007/s40336-021-00426-z.
Kumar R, Chauhan A, Zhuang H, et al. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat. 2006;98(3):267-74. doi:10.1007/s10549-006-9159-2.
Чёрная А.В., Канаев С.В., Новиков С.Н., и др. Маммография и маммосцинтиграфия с 99м Тс-MIBI в диагностике мультицентричного рака молочной железы. Вопросы Онкологии. 2017;63(6):876-881 [Chernaya AV, Kanaev SV, Novikov SN, et al. Mammography and mammoscintigraphy with 99m Тс-MIBI in the diagnosis of multicentric breast cancer. Voprosy Onkologii. 2017;63(6):876-81 (In Russ).]. doi:10.37469/0507-3758-2017-63-6-876-881.
Канаев C.В., Новиков С.Н., Семиглазов В.Ф., и др. Возможности раннего выявления новообразований рака молочной железы с помощью ультразвуковых и радионуклидных методов диагностики. Вопросы онкологии. 2011;57(5):622-626 [Kanaev SV, Novikov SN, Semiglazov VF, et al. Possibilities of early detection of breast cancer neoplasms using ultrasound and radionuclide diagnostic methods. Voprosy onkologii. 2011;57(5):622-626 (In Russ.)].
Вернадский Р.Ю., Медведева А.А., Гарбуков Е.Ю., и др. Радионуклидные методы исследования на этапах диагностики и лечения рака молочной железы. Сибирский медицинский журнал. 2018;33(4):44-53 [Vernadsky RYu, Medvedeva AA, Garbukov EYu, et al. Radionuclide research methods at the stages of diagnosis and treatment of breast cancer. The Siberian Scientific Medical Journal. 2018;33(4):44-53 (In Russ.)]. doi:10.29001/2073-8552-2018-33-4-44-53.
Чёрная А.В., Крживицкий П.И., Бусько Е.А., Криворотько П.В., и др. Роль цифровой маммографии, маммосцинтиграфии с 99mTc-метоксиизобутилизонитрилом (MIBI) и ультразвукового исследования в диагностике мультицентричного рака молочной железы//Опухоли женской репродуктивной системы. 2019;14(4):12-22 [Chernaya AV, Krzhivitskiy PI, Busko EA, Krivorotko PV, et al. The role of digital mammography, scintimammography with 99mTc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer. Tumors of female reproductive system. 2020;15(4):12-22 (In Russ.)]. doi:10.17650/1994-4098-2019-15-4-12-22.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2023